Equities Analysts Offer Predictions for Teleflex Q3 Earnings

Teleflex Incorporated (NYSE:TFX - Free Report) - Stock analysts at Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for Teleflex in a research report issued on Thursday, May 15th. Zacks Research analyst R. Department now anticipates that the medical technology company will post earnings per share of $3.37 for the quarter, down from their prior estimate of $3.54. The consensus estimate for Teleflex's current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex's Q2 2026 earnings at $3.93 EPS, Q3 2026 earnings at $3.80 EPS and Q1 2027 earnings at $3.67 EPS.

Several other research firms also recently issued reports on TFX. Piper Sandler reaffirmed a "neutral" rating and set a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Bank of America downgraded Teleflex from a "neutral" rating to an "underperform" rating and cut their price target for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. StockNews.com downgraded Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Truist Financial cut their price target on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. Finally, Wells Fargo & Company cut their price target on Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a research note on Friday, May 2nd. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $164.63.

Teleflex Trading Up 2.1%

NYSE:TFX opened at $129.15 on Monday. The company has a market capitalization of $5.71 billion, a PE ratio of 25.67, a price-to-earnings-growth ratio of 1.73 and a beta of 1.17. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex has a 52-week low of $120.06 and a 52-week high of $249.91. The stock has a fifty day simple moving average of $132.83 and a 200-day simple moving average of $162.37.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business's revenue was down 5.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.21 EPS.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. raised its stake in Teleflex by 0.7% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company's stock valued at $859,095,000 after purchasing an additional 43,642 shares during the last quarter. Geode Capital Management LLC grew its holdings in Teleflex by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company's stock valued at $202,161,000 after buying an additional 8,307 shares during the period. Cooke & Bieler LP grew its holdings in Teleflex by 22.1% in the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock valued at $191,962,000 after buying an additional 195,150 shares during the period. Invesco Ltd. grew its holdings in Teleflex by 48.1% in the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock valued at $190,188,000 after buying an additional 347,003 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in Teleflex by 69.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company's stock valued at $119,927,000 after buying an additional 355,720 shares during the period. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.05%. The ex-dividend date is Tuesday, May 20th. Teleflex's payout ratio is 42.90%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.